Home/Pipeline/Emblok 360°

Emblok 360°

Embolic Protection during Transcatheter Aortic Valve Replacement (TAVR) and other left-heart procedures

Pre-clinicalActive

Key Facts

Indication
Embolic Protection during Transcatheter Aortic Valve Replacement (TAVR) and other left-heart procedures
Phase
Pre-clinical
Status
Active
Company

About Innovative Cardiovascular Solutions

Innovative Cardiovascular Solutions is a clinical-stage medical device company developing the Emblok 360° embolic protection system. The device is designed to capture particulate debris during transcatheter aortic valve replacement (TAVR) and other left-heart procedures to protect the brain, heart, kidneys, and intestines from embolic injury, thereby aiming to reduce stroke risk and other major complications. The company is led by an experienced executive team and supported by a prominent scientific advisory board of interventional cardiologists. It is positioned in the high-growth structural heart market but faces significant competition and the need to demonstrate clinical and economic value to achieve adoption.

View full company profile

Therapeutic Areas